December 21, 2013

Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis

.   .   

This randomized trial compared rituximab with cyclophosphamide followed by azathioprine in severe ANCA-associated vasculitis. This noninferiority trial showed that there was no difference at 18 months for the induction and maintenance of remissions between groups.

Related Articles:

Clinical Nephrology, Clinical Trial Results, Glomerulonephritis, Vasculitis

Comments are closed.